<DOC>
	<DOCNO>NCT02810262</DOCNO>
	<brief_summary>Mortality due non small cell lung cancer first cause cancer death men around world . Lung adenocarcinoma regularly induces bone metastases responsible high morbidity impair life quality . Overall survival patient poor . Thus investigator aim identify bone metabolic parameter associate overall survival . Patients Methods POUMOS prospective cohort patient suffer adenocarcinoma lung cancer first bone metastasis ( stage IV ) . All patient bone biopsy molecular status characterization tumor EGFR , KRAS , BRAF ALK . Bone metastasis localization obtain bone scintigraphy FDG-PET/CT . Whole body composition obtain DEXA scan ( HologicÂ® ) . The investigator assess also fast blood level bone metabolic biomarkers . Survival analysis perform use proportional hazard regression model .</brief_summary>
	<brief_title>Association Bone Metabolic Parameters With Overall Survival Patients With Bone Metastases From Adenocarcinoma Lung Cancer ( POUMOS )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>adult 18 year gender cover French National Insurance first bone metastases adenocarcinoma lung cancer ( synchronous metachrone ) adenocarcinoma previously treat systemic oncologic treatment ( chemotherapy , target therapy , immunotherapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Lung cancer</keyword>
	<keyword>Bone metastasis</keyword>
	<keyword>EGFR</keyword>
	<keyword>KRAS</keyword>
	<keyword>Bone biomarkers</keyword>
	<keyword>Metabolic parameter</keyword>
</DOC>